Arie Belldegrun

Insider Reports History

Entity
Individual
Location
Ucla School Of Medicine, 10833 Le Conte 66 118 Chs Box 951738, Los Angeles, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arie Belldegrun:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Director Stock Option (Right to buy) 1.31M $7.21M $9.62 Jan 24, 2025 Direct
Allogene Therapeutics, Inc. Director Common Stock 2.24M $3.98M $1.78 Jan 24, 2025 Direct
Allogene Therapeutics, Inc. Director Common Stock 540K $961K $1.78 Jan 24, 2025 Indirect
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 500K $275K $0.55 Jun 12, 2024 By Bellco Legacy LLC
Ginkgo Bioworks Holdings, Inc. Director Restricted Stock Units 433K $238K $0.55 Jun 13, 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 195K $107K $0.55 Jun 12, 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Stock Option 571K Jun 13, 2024 Direct
Kronos Bio, Inc. Director Stock Option (Right to Buy) 34K Jun 25, 2024 Direct
UroGen Pharma Ltd. Director Stock Option (right ot buy) 10K Aug 6, 2024 Direct

Insider Reports Filed by Arie Belldegrun

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Jan 24, 2025 2 $0 4 Jan 28, 2025 Director
URGN UroGen Pharma Ltd. Aug 6, 2024 1 $0 4 Aug 8, 2024 Director
KRON Kronos Bio, Inc. Jun 25, 2024 1 $0 4 Jun 26, 2024 Director
DNA Ginkgo Bioworks Holdings, Inc. Jun 12, 2024 4 $0 4 Jun 14, 2024 Director
ALLO Allogene Therapeutics, Inc. May 16, 2024 2 $6M 4 May 20, 2024 Director
ALLO Allogene Therapeutics, Inc. Jan 25, 2024 2 $0 4 Jan 31, 2024 Director
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Director
KRON Kronos Bio, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
DNA Ginkgo Bioworks Holdings, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
ALLO Allogene Therapeutics, Inc. Mar 22, 2023 2 $0 4 Mar 24, 2023 Director
URGN UroGen Pharma Ltd. Sep 14, 2022 2 $800K 4 Sep 16, 2022 Director
URGN UroGen Pharma Ltd. Aug 31, 2022 2 $16.2K 4 Sep 2, 2022 Director
KRON Kronos Bio, Inc. Jun 22, 2022 1 $0 4 Jun 29, 2022 Director
DNA Ginkgo Bioworks Holdings, Inc. Jun 10, 2022 2 $0 4 Jun 13, 2022 Director
URGN UroGen Pharma Ltd. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
ALLO Allogene Therapeutics, Inc. Mar 23, 2022 1 $0 4 Mar 25, 2022 Director
ALLO Allogene Therapeutics, Inc. Mar 14, 2022 2 $0 4/A Apr 1, 2022 Director
ALLO Allogene Therapeutics, Inc. Jan 12, 2022 1 $1.95M 4 Jan 14, 2022 Director
DNA Ginkgo Bioworks Holdings, Inc. Sep 16, 2021 0 $0 3/A Mar 28, 2022 Director
KRON Kronos Bio, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director
URGN UroGen Pharma Ltd. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director
ALLO Allogene Therapeutics, Inc. May 24, 2021 2 $6.91M 4 May 25, 2021 Director
URGN UroGen Pharma Ltd. Mar 26, 2021 2 $16.2K 4/A Jun 9, 2021 Director